Kurt P. Losert

Mar 23, 2023 | nature.com | Travis Zack |Atul J. Butte |Ghassan Abou Alfa |Kurt P. Losert

AbstractThe incidence and biochemical consequences of rare tumor subtypes are often hard to study. Fibrolamellar liver cancer (FLC) is a rare malignancy affecting adolescents and young adults. To better characterize the incidence and biochemical consequences of this disease, we combined a comprehensive analysis of the electronic medical record and national payer data and found that FLC incidence is likely five to eight times higher than previous estimates.